How to Improve Diversity in Clinical Trials: A Practical Guide for Pharma Teams
Published: 05 Jun 2026
Improving diversity in clinical trials is no longer optional for pharma teams. FDA guidance, public scrutiny, and the moral imperative of equitable research all point in the same direction: trials must reflect the communities they serve.
Elevate Impact connects pharma, advocacy groups, and clinical researchers on a rare disease collaboration platform designed to support inclusive enrollment from the earliest planning stages — not as an afterthought.
Start with advocacy partnerships
Patient advocacy organizations hold trust, community knowledge, and lived experience that protocols alone cannot capture. Partner early to co-design recruitment strategies and inclusion criteria.
Build community-engaged trial design
Engage communities before finalizing protocols. Use structured collaboration tools to identify barriers to participation and address them in study design.
Leverage cross-sector infrastructure
Platforms like Elevate Impact provide the connective tissue between pharma, hospitals, and advocacy — reducing the fragmentation that slows diverse enrollment.
